Related references
Note: Only part of the references are listed.Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis
Maximilian Larena et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Possible allelic structure of IgG2a and IgG2c in mice
Zhiping Zhang et al.
MOLECULAR IMMUNOLOGY (2012)
Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model
Yize Li et al.
VIROLOGY JOURNAL (2012)
Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms
Matthew R. Vogt et al.
JOURNAL OF VIROLOGY (2011)
Pivotal Role of Antibody and Subsidiary Contribution of CD8+ T Cells to Recovery from Infection in a Murine Model of Japanese Encephalitis
Maximilian Larena et al.
JOURNAL OF VIROLOGY (2011)
Ecology and Geographical Expansion of Japanese Encephalitis Virus
Andrew F. van den Hurk et al.
ANNUAL REVIEW OF ENTOMOLOGY (2009)
B Cell Intrinsic MyD88 Signals Drive IFN-γ Production from T Cells and Control Switching to IgG2c
Tom A. Barr et al.
JOURNAL OF IMMUNOLOGY (2009)
Antibody recognition of cell surface-associated NS1 triggers Fc-γ receptor-mediated phagocytosis and clearance of West Nile virus-infected cells
Kyung Min Chung et al.
JOURNAL OF VIROLOGY (2007)
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection
Bimmi Shrestha et al.
JOURNAL OF VIROLOGY (2006)
Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy
Y Hamaguchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc γ receptor-dependent and -independent mechanisms
KM Chung et al.
JOURNAL OF VIROLOGY (2006)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
FcγRIV:: A novel FcR with distinct IgG subclass specificity
F Nimmerjahn et al.
IMMUNITY (2005)
Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, Whereas T- and B-cell-dependent immunity are less critical
S Shresta et al.
JOURNAL OF VIROLOGY (2004)
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses
JS Mackenzie et al.
NATURE MEDICINE (2004)
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice
MJ Engle et al.
JOURNAL OF VIROLOGY (2003)
T-bet regulates IgG class switching and pathogenic autoantibody production
SL Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants
D Markine-Goriaynoff et al.
JOURNAL OF VIROLOGY (2002)
Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine:: Requirement for antibody but not CD8+ cytotoxic T-cell responses
CH Pan et al.
JOURNAL OF VIROLOGY (2001)
A purified inactivated Japanese encephalitis virus vaccine made in vero cells
AK Srivastava et al.
VACCINE (2001)
Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections
VC Huber et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines
L Pricop et al.
JOURNAL OF IMMUNOLOGY (2001)
Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient mice
LE Smythies et al.
JOURNAL OF IMMUNOLOGY (2000)
Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcγ receptor III
L Fossati-Jimack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)